Update in Contrast Induced Nephropathy

Size: px
Start display at page:

Download "Update in Contrast Induced Nephropathy"

Transcription

1 Update in Contrast Induced Nephropathy Yves Pirson Service de Néphrologie, Clin. Univ. St-Luc - UCL

2 A 76-year-old man with - type 2 diabetes - CKD (ser. creat.: 1.8 mg/dl; GFR: 32) presents with angina pectoris indication for elective coronarography

3 Course of kidney function Ser. Créat.: (mg/dl) Coro Definition of CIN : - either in ser. creat. > 0.5 mg/dl - or > 25% increase in ser. creat Day

4 Risk score for prediction of CIN after percutaneous coronary intervention Risk factor Score Age > 75 4 Diabetes 3 Systolic BP < 80 mmhg durant > 1h 5 GFR Contrast volume 1/100 ml Risk score Risk of CIN (%) Risk of dialysis (%) > (Mehran R et al., J Am Coll Cardiol 2004; 44: 1393)

5 Prevalence of CKD in the US (Andersen PE, World J Radiol 2012; 4: 253)

6 Is it important to avoid CIN? Pathophysiology of CIN Risk factors for developing CIN How to prevent CIN?

7

8 (Maioli M, Circulation 2012; 125: 3099)

9 (Maioli M, Circulation 2012;125:3099)

10 12% 2% (Maioli M, Circulation 2012; 125: 3099)

11 Effect of acute kidney injury frequency on survival to stage 4 CKD (Chawla LS, Kidney Int 2012; 82: 516)

12 (Chawla LS, Kidney Int 2012; 82: 516)

13 Is it important to avoid CIN? Pathophysiology of CIN Risk factors for developing CIN How to prevent CIN?

14 (Calvin AD, Nat Rev Nephrol 2010; 6: 679)

15 (Calvin AD, Nat Rev Nephrol 2010; 6: 679)

16 Is it important to avoid CIN? Pathophysiology of CIN Risk factors for developing CIN How to prevent CIN?

17 Patient-related risk factors for CIN Classical Age > 70 CKD Diabetes mellitus Congestive heart failure Dehydration (! diuretics) Use of nephrotoxic drugs (NSAID, anticalcineurins, some antivirals) Recently recognized risk factors for AKI in general Obesity (Soto GJ, Crit Care Med 2012; 40: 260) Albuminuria with preserved egfr

18 Adjusted hazard ratio for acute kidney injury according to egfr and albuminuria Albumin-to-creatinine ratio > 300 mg/g mg/g < 30 mg/g (Gansevoort R, Kidney Int 2011; 80:93)

19 Is it important to avoid CIN? Pathophysiology of CIN Risk factors for developing CIN How to prevent CIN?

20 How to prevent CIN? Assessment of the individual risk for CIN Minimisation of this risk Volume expansion Pharmacological prevention? Non-pharmacological preconditioning? Clinical practice

21 Screening of the population at risk for CIN Ser. creat. in all patients at risk : egfr < 45 Simple risk-factor questionnaire : - known CKD? - diabetes? - c-v disease? - list of current medications - contrast media within the last 3 days? Urinary-protein screening advisable

22 In patients with increased risk : is contrast injection absolutely needed?

23 How to prevent CIN? Assessment of the individual risk for CIN Minimisation of this risk Volume expansion Pharmacological prevention? Non-pharmacological preconditioning? Clinical practice

24 Minimisation of the risk Discontinue concurrent nephrotoxic medications (NSAID, diuretics) whenever possible for > 3 days No compelling reason to discontinue ACE-I/ARB Avoid repeat contrast injection within 72 hours Use the lowest volume of contrast Apply a prevention protocol

25 Which prevention strategy?

26 How to prevent CIN? Assessment of the individual risk for CIN Minimisation of this risk Volume expansion Pharmacological prevention? Non-pharmacological preconditioning? Clinical practice

27 «Despite the recognition of volume depletion as an important risk factor for AKI, there are no RCT that have directly evaluated the role of fluids vs placebo in the prevention of AKI» (KDIGO) There is however a large consensus as to recommend volume expansion in at-risk patients But : Oral or i-v? Na chloride or bicarbonate?

28 (n = 79) NaCl 1g/10kg/d per os for 2 days (n = 77) 0.9% NaCl i.v. 15 ml/kg for 6 h before (n = 80) idem arm B + theophylline 5mg/kg 1 h before (n = 79) idem arm B + furosemide 3mg/kg i.v. after

29 Arm A (n = 27) NaCl i.v. 1 h before 6 h after Arm B (n = 21) Bicar i.v. 1 h before 6 h after Arm C (n = 22) Oral H 2 O 500 ml before 600 ml after Arm D (n = 21) Idem C + oral bicar 4g before and 2g after

30 Oral route vs i-v route «We recommend not using oral fluids alone in patients at increased risk of CIN» KDIGO. Kidney Int 2012; Suppl 2: 69 «We suggest using the oral route for hydratation, on the premise that adequate intake of fluid and salt are assured (2C). We suggest that, when oral intake of fluid and salt is deemed cumbersome in patients at increased risk of CIN, hydration should be performed by intravenous route (2C)» ERBP. Nephrol Dial Transplant 2012; 27: 4263

31 Clinical trials comparing i-v bicarbonate with i-v saline for CIN (Weisbord SD, Clin J Am Soc Nephrol 2013;8: 1618)

32 Meta-analyses of bicarbonate vs saline for CIN prevention (Weisbord SD, Clin J Am Soc Nephrol 2013;8: 1618)

33 «We recommend volume expansion with either isotonic sodium chloride or sodium bicarbonate solutions, rather than no volume expansion, in patients at increased risk for CIN (1A)» KDIGO and ERBP 2012

34 How to prevent CIN? Assessment of the individual risk for CIN Minimisation of this risk Volume expansion Pharmacological prevention? Non-pharmacological preconditioning? Clinical practice

35 83 patients ser.creat ~ 2,4 mg/dl enhanced CT NaCl 0.45 % i-v 12h before 12h after + NAC 600 mg 2x/j J-1 and J0 (Tepel M et al. N Engl J Med 2000; 343: 180-4)

36 Clinical trials comparing NAC with placebo for CIN prevention 15 positive vs 21 negative studies 17 meta-analyses with conflicting conclusions! «We suggest using oral NAC, together with i.v. isotonic cristalloids, in patients at increased risk of CIN (2D)» KDIGO «We suggest using oral N-acetyl-cysteine (NAC) only in patients who receive appropriate fluid and salt loading (2D). We recommend not using oral NAC as the only method for prevention of CIN (1D)» ERBP

37 2 x 2 factorial design - bicarbonate vs saline - NAC vs placebo 90-day composite end-point (death or dialysis or persistant decline in kidney function) > participants, USA and Australia (Weisbord SD, Clin J Am Soc Nephrol 2013;8: 1618)

38 Atorvastatin 80 mg within 24 h before contrast vs placebo + Bicarbonate and NAC in all patients (Quintavalle C, Circulation 2012; 126: 3008)

39 9 RCTs, 1536 patients 33% less risk of CIN among patients receiving ascorbic acid

40 How to prevent CIN? Assessment of the individual risk for CIN Minimisation of this risk Volume expansion Pharmacological prevention? Non-pharmacological preconditioning? Clinical practice

41 Preconditioning : 4 cycles of alternating 5 inflation and 5 deflation of a standard BP cuff to the individual SBP + 50 mmhg, within 1 before coronarography 50 pts vs 50 controls S creat > 1.4 mg/dl or egfr < 60 (Er F, Circulation 2012; 126: 296)

42 Regional Ischemic Preconditioning Protects Remote Virgin Myocardium From Subsequent Sustained Coronary Occlusion Przyklenk K, Circulation 1993; 87: 893

43 Effect of IPC on serum creatinine (Wever KE, PlosOne 2012;7: e32296)

44 What is the molecular mechanism(s) behind ischemic preconditioning? inducible NO (Park KM, 2003)? adenosine (Wever KE, 2011)? hypoxia inducible factor 1 α (Malfoud, 2012)?.

45

46 How to prevent CIN? Assessment of the individual risk for CIN Minimisation of this risk Volume expansion Pharmacological prevention? Non-pharmacological preconditioning? Clinical practice

47 Conclusions 1. Among at-risk patients (age >75; suspicion of CKD; diabetes, congestive heart failure etc ) check egfr 2. If egfr < 40 : - discontinuation diuretics, NSAID - i-v saline 1 ml/kg/h for 24 h - use the lowest dose of contrast

48

49 (Bolognese L, Am J Cardiol 2012; 190:67)

50 (Gurm H, J Am Coll Cardiol 2011; 58:907)

La prevenzione della nefropatia da contrasto nel paziente cardiologico. Carlo Guastoni U.O. Nefrologia Ospedale Civile di Legnano

La prevenzione della nefropatia da contrasto nel paziente cardiologico. Carlo Guastoni U.O. Nefrologia Ospedale Civile di Legnano La prevenzione della nefropatia da contrasto nel paziente cardiologico. Carlo Guastoni U.O. Nefrologia Ospedale Civile di Legnano CIN (CI-AKI) definition Both clinical studies and ESUR definition (Thomsen

More information

Nierfunctiemeting en follow-up van chronisch nierlijden

Nierfunctiemeting en follow-up van chronisch nierlijden Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated

More information

Nefropatia de Contraste

Nefropatia de Contraste Nefropatia de Contraste H. Luz Rodrigues Serviço de Nefrologia e Transplantação Instituto de Farmacologia e Neurociências Contrast-induced nephropathy Agenda Pathogenesis Clinical features Prevention Postulated

More information

Trust Guideline. for. The Prevention of Contrast Induced Nephropathy (CIN) in Adults by the Administration of Intravenous Hydration

Trust Guideline. for. The Prevention of Contrast Induced Nephropathy (CIN) in Adults by the Administration of Intravenous Hydration Trust Guideline for The Prevention of Contrast Induced Nephropathy (CIN) in Adults by the Administration of Intravenous Hydration Protocol for patients with impaired renal function undergoing planned angiography

More information

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:

More information

Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration

Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Hiddo Lambers Heerspink Department of Clinical Pharmacology University Medical

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

Protocol for the safe administration of iodinated contrast media in diagnostic radiology

Protocol for the safe administration of iodinated contrast media in diagnostic radiology Protocol for the safe administration of iodinated contrast media in diagnostic radiology Protocol statement: This protocol applies to all staff within Radiology Departments at Heart of England NHS Foundation

More information

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic THE GEORGE INSTITUTE FOR GLOBAL HEALTH Antiocoagulation in diabetes and CKD Vlado Perkovic Executive Director, George Institute Australia Professor of Medicine, University of Sydney Affiliated with the

More information

IS N-ACETYLCYSTEINE USEFUL IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY? A REVIEW

IS N-ACETYLCYSTEINE USEFUL IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY? A REVIEW The West London Medical Journal 2010 Vol 2 No 2 pp 35-39 IS N-ACETYLCYSTEINE USEFUL IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY? INTRODUCTION A REVIEW Yogesh Kalaiah, Jayantha Arnold The increasing use

More information

CONTRAST. (COntrast media and NephroToxicity following coronary Revascularization by AngioplaSTy)

CONTRAST. (COntrast media and NephroToxicity following coronary Revascularization by AngioplaSTy) Randomized clinical trial to compare the nephrotoxic effects of iso osmolar vs. low osmolar contrast medium in patients with impaired renal function undergoing PCI CONTRAST (COntrast media and NephroToxicity

More information

CHRONIC KIDNEY DISEASE

CHRONIC KIDNEY DISEASE MANAGEMENT OF CHRONIC KIDNEY DISEASE IN ADULTS KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family

More information

Kidney Disease Dr. Eoin Bergin

Kidney Disease Dr. Eoin Bergin Kidney Disease Dr. Eoin Bergin Consultant Nephrologist Midlands Regional Hospital, Tullamore 10 Years in Tullamore The Kidney has 2 main functions: Maintaining a constant extracellular environment Removing

More information

Getting smart about dyspnea and life saving drug therapy in ACS patients. Kobi George Kaplan Medical Center Rehovot

Getting smart about dyspnea and life saving drug therapy in ACS patients. Kobi George Kaplan Medical Center Rehovot Getting smart about dyspnea and life saving drug therapy in ACS patients Kobi George Kaplan Medical Center Rehovot 78 year old female Case description Presented with resting chest pain and dyspnea Co morbidities:

More information

KDIGO Clinical Guidelines for Management of AKI

KDIGO Clinical Guidelines for Management of AKI KDIGO Clinical Guidelines for Management of AKI Noel Gibney MB FRCP(C) Professor, Division of Critical Care Medicine University of Alberta Disclosure Gambro: Expert Panel Fellowship Funding Kidney Int

More information

Guideline for the Administration of IV Contrast Media in Patients at Risk of Contrast Induced Nephrotoxicity (CIN)

Guideline for the Administration of IV Contrast Media in Patients at Risk of Contrast Induced Nephrotoxicity (CIN) A clinical guideline/policy For use in: By: For: Division responsible for document: Key words: Names and job titles of document authors: Name of document authors Line Manager: Job title of authors Line

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

Diabetic Kidney Disease AADE Practice Advisory Issued November 21, 2013

Diabetic Kidney Disease AADE Practice Advisory Issued November 21, 2013 Diabetic Kidney Disease AADE Practice Advisory Issued November 21, 2013 Major risk factors for kidney disease include high blood pressure, diabetes, cardiovascular disease and family history of kidney

More information

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care

Southern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care Southern Derbyshire Shared Care Pathology Guidelines AKI guidelines for primary care Contents: FLOW DIAGRAM: MANAGEMENT OF PATIENTS WITH AKI DETECTED IN PRIMARY CARE...2 FLOW DIAGRAM: POST AKI MANAGEMENT

More information

8. Strategies in Patients at Risk for Allergic Reactions to IV Contrast for CT

8. Strategies in Patients at Risk for Allergic Reactions to IV Contrast for CT Updated 7/14/09 UAB Department of Radiology Guidelines for Administering Gadolinium-based and Iodine-based Intravenous Contrast Agents in Patients with Renal Dysfunction or at Risk for Adverse Reactions

More information

ASSESSMENT OF RENAL FUNCTION

ASSESSMENT OF RENAL FUNCTION ASSESSMENT OF RENAL FUNCTION Anita N. Jackson, Pharm.D. Spring 2012 Laboratory Tests to Assess Renal Function Serum Creatinine (SCr) Breakdown product of creatine metabolism Renal elimination only (90%

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

ΠΟΙΟ ΑΝΤΙΠΗΚΤΙΚΟ ΓΙΑ ΤΟΝ ΑΣΘΕΝΗ ΜΟΥ? ΚΛΙΝΙΚΑ ΠΑΡΑΔΕΙΓΜΑΤΑ. Σωκράτης Παστρωμάς Καρδιολόγος Νοσοκομείο Ερρίκος Ντυνάν

ΠΟΙΟ ΑΝΤΙΠΗΚΤΙΚΟ ΓΙΑ ΤΟΝ ΑΣΘΕΝΗ ΜΟΥ? ΚΛΙΝΙΚΑ ΠΑΡΑΔΕΙΓΜΑΤΑ. Σωκράτης Παστρωμάς Καρδιολόγος Νοσοκομείο Ερρίκος Ντυνάν ΠΟΙΟ ΑΝΤΙΠΗΚΤΙΚΟ ΓΙΑ ΤΟΝ ΑΣΘΕΝΗ ΜΟΥ? ΚΛΙΝΙΚΑ ΠΑΡΑΔΕΙΓΜΑΤΑ Σωκράτης Παστρωμάς Καρδιολόγος Νοσοκομείο Ερρίκος Ντυνάν The AF epidemic Mayo Clinic data (assuming a continued increase in the AF incidence) Mayo

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

Chronic Kidney Disease: Proposed Revisions to the ICD-9-CM Classification

Chronic Kidney Disease: Proposed Revisions to the ICD-9-CM Classification Chronic Kidney Disease: Proposed Revisions to the ICD-9-CM Classification Lesley Stevens MD Tufts-New England Medical Center National Kidney Foundation Objectives Kidney Failure Stages of Chronic Kidney

More information

Chronic Kidney Disease (CKD)Management in General Practice SUMMARY GUIDE

Chronic Kidney Disease (CKD)Management in General Practice SUMMARY GUIDE Chronic Kidney Disease (CKD)Management in General Practice SUMMARY GUIDE Early detection of CKD using kidney health check Who is at higher risk of kidney disease? Age > 50 years Diabetes High blood pressure

More information

135 mmhg 85 [3] JNC mmhg 90 mmhg 120 mmhg 80 mmhg [1] 60 ml/min/1.73m 2 6.9% 1. (GFR)

135 mmhg 85 [3] JNC mmhg 90 mmhg 120 mmhg 80 mmhg [1] 60 ml/min/1.73m 2 6.9% 1. (GFR) JNC 7 2003 140 mmhg 90 mmhg 120 mmhg80 mmhg [1] 95 135 mmhg85 mmhg 24 135 mmhg 85 mmhg [2] 2000 2025 [3] 60 ml/min/1.73m 2 [4] ( 1) 6.9% 1. (GFR) 1 90 2 60-89 3 30-59 4 15-29 5 15 ( ) 64 96 19 2 71.4%

More information

VKA in Dialysis: Navigating between Scylla and Charybdis. An De Vriese Nephrology & Infectious Diseases AZ Sint-Jan Brugge

VKA in Dialysis: Navigating between Scylla and Charybdis. An De Vriese Nephrology & Infectious Diseases AZ Sint-Jan Brugge VKA in Dialysis: Navigating between Scylla and Charybdis An De Vriese Nephrology & Infectious Diseases AZ Sint-Jan Brugge AF in Dialysis DOPPS I (1996 2001) and DOPPS II (2002 2004) Wizeman V et al. Kidney

More information

Contrast medium-induced nephropathy: critical review of the existing clinical evidence

Contrast medium-induced nephropathy: critical review of the existing clinical evidence Nephrol Dial Transplant (2005) 20 [Suppl 1]: i12 i17 doi:10.1093/ndt/gfh1067 Contrast medium-induced nephropathy: critical review of the existing clinical evidence Michael A. Bettmann Dartmouth-Hitchcock

More information

Guideline on CKD. Bertram Kasiske, MD Mandaluyong City April 23, Kidney Disease: Improving Global Outcomes.

Guideline on CKD. Bertram Kasiske, MD Mandaluyong City April 23, Kidney Disease: Improving Global Outcomes. Guideline on CKD Bertram Kasiske, MD Mandaluyong City April 23, 2014 What is CKD? When bubbles settle on the surface of the urine, they indicate disease of the kidneys, and that the complaint will be protracted.

More information

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,

More information

Comparative Effectiveness of Interventions for Secondary Prevention of Atrial Fibrillation Following Ablation. Larisa Tereshchenko, MD, PhD

Comparative Effectiveness of Interventions for Secondary Prevention of Atrial Fibrillation Following Ablation. Larisa Tereshchenko, MD, PhD Comparative Effectiveness of Interventions for Secondary Prevention of Atrial Fibrillation Following Ablation Larisa Tereshchenko, MD, PhD Rationale for trial: Atrial fibrillation (AF) is associated with

More information

HOSPITAL ACQUIRED ACUTE RENAL FAILURE/ACUTE KIDNEY INJURY CHANGE PACKAGE. Prevention of Hospital Acquired Acute Renal Failure/Acute Kidney Injury

HOSPITAL ACQUIRED ACUTE RENAL FAILURE/ACUTE KIDNEY INJURY CHANGE PACKAGE. Prevention of Hospital Acquired Acute Renal Failure/Acute Kidney Injury HOSPITAL ACQUIRED ACUTE RENAL FAILURE/ACUTE KIDNEY INJURY CHANGE PACKAGE Prevention of Hospital Acquired Acute Renal Failure/Acute Kidney Injury Table of Contents OVERVIEW..........................................................

More information

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

HYPERTENSION ASSOCIATED WITH RENAL DISEASES RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

SAFE ANALGESIC USE IN CHRONIC KIDNEY DISEASE

SAFE ANALGESIC USE IN CHRONIC KIDNEY DISEASE 1 Doctor, I m in Pain! SAFE ANALGESIC USE IN CHRONIC KIDNEY DISEASE Ma Yuet Ting, BCACP Senior Pharmacist Khoo Teck Puat Hospital 2 Outline Common analgesics in CKD Paracetamol NSAIDs & Cox-2 Inhibitors

More information

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Models of Chronic Kidney Disease Care and Initiation of Dialysis Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Early Crash Landings Talk Outline Pathways & Definitions Guideline recommendations

More information

Treatment of cardiogenic shock

Treatment of cardiogenic shock ACUTE HEART FAILURE AND COMORBIDITY IN THE ELDERLY Treatment of cardiogenic shock Christian J. Wiedermann, M.D., F.A.C.P. Associate Professor of Internal Medicine, Medical University of Innsbruck, Austria

More information

Detecting and managing Chronic Kidney Disease

Detecting and managing Chronic Kidney Disease Detecting and managing Chronic Kidney Disease KCAT Primary Care Nurse Workshop Conceived and developed by the Kidney Check Australia Taskforce sub-committee for education in nursing in general practice

More information

Acute Renal Failure. usually a consequence.

Acute Renal Failure. usually a consequence. Acute Renal Failure usually a consequence www.philippelefevre.com Definitions Pathogenisis Classification ICU Incidence/ Significance Treatments Prerenal Azotaemia Blood Pressure Cardiopulmonary Baroreceptors

More information

Paediatric CTA: nephrotoxic complications in high concentration iodinated contrast medium administration in children with congenital heart disease

Paediatric CTA: nephrotoxic complications in high concentration iodinated contrast medium administration in children with congenital heart disease Paediatric CTA: nephrotoxic complications in high concentration iodinated contrast medium administration in children with congenital heart disease Poster No.: C-2319 Congress: ECR 2016 Type: Scientific

More information

10/27/2010. CKD in the United States. Management of The Patient With Chronic Kidney Disease. CKD Patients Are More Likely to Die Than Progress to ESRD

10/27/2010. CKD in the United States. Management of The Patient With Chronic Kidney Disease. CKD Patients Are More Likely to Die Than Progress to ESRD CKD in the United States Management of The Patient With Chronic Kidney Disease Paul J. Scheel, Jr., M.D., FASN Director,Division of Nephrology An estimated 26 million adults have CKD Many are unaware of

More information

The Impact of Whole Blood Creatinine Testing Accuracy on Screening for Medical Imaging

The Impact of Whole Blood Creatinine Testing Accuracy on Screening for Medical Imaging The Impact of Whole Blood Creatinine Testing Accuracy on Screening for Medical Imaging Presenter: Brad S. Karon MD, PhD We will begin shortly. If you need assistance with audio, call 866 863 3904. The

More information

Hypoglycemia (Technician-Paramedic) Protocol revised October 2008

Hypoglycemia (Technician-Paramedic) Protocol revised October 2008 Hypoglycemia (Technician-Paramedic) Protocol revised October 2008 Preamble Prolonged hypoglycemia may result in serious neurologic complications and death. Glucose and glucagon can be administered to correct

More information

Statistics for the intensivist (1) ICU Fellowship Training Radboudumc

Statistics for the intensivist (1) ICU Fellowship Training Radboudumc Statistics for the intensivist (1) ICU Fellowship Training Radboudumc Presenting and summarising data Gaining familiarity with the data Looking for outliers Checking the assumptions for statistical testing

More information

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI

More information

HYPERKALEMIA. Best Practices in Managing. in Chronic Kidney Disease

HYPERKALEMIA. Best Practices in Managing. in Chronic Kidney Disease + Best Practices in Managing HYPERKALEMIA in Chronic Kidney Disease Hyperkalemia in Chronic Kidney Disease (CKD) Treatment with RAAS Inhibitors (RAASi) in CKD Diagnosis and Evaluation of Hyperkalemia Treatment

More information

Antiplatelet and Antithrombotics From clinical trials to guidelines

Antiplatelet and Antithrombotics From clinical trials to guidelines Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories

More information

Guideline for Microalbuminuria Screening

Guideline for Microalbuminuria Screening East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network

More information

Continuous Renal Replacement Therapy. Jai Radhakrishnan, MD, MS

Continuous Renal Replacement Therapy. Jai Radhakrishnan, MD, MS Continuous Renal Replacement Therapy Jai Radhakrishnan, MD, MS History of the CRRT program 1988 Open heart program Active transplant program Deep dissatisfaction with peritoneal dialysis in hemodynamically

More information

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Naftali Stern Institute of Endocrinology, Metabolism and Hypertension Tel Aviv -Sourasky Medical Center and Sackler

More information

Approach to Acute Kidney Injury. What is acute kidney injury (AKI)? Sarah Faubel, MD. What is AKI?

Approach to Acute Kidney Injury. What is acute kidney injury (AKI)? Sarah Faubel, MD. What is AKI? Approach to Acute Kidney Injury Sarah Faubel, MD What is acute kidney injury (AKI)? What is AKI? Acute Dialysis Quality Initiative (ADQI), National Kidney Foundation (NKF), Kidney Disease: Improving Global

More information

The New Role of STAT Creatinine Testing Presenter: Brad S. Karon MD, PhD. Sponsored by

The New Role of STAT Creatinine Testing Presenter: Brad S. Karon MD, PhD. Sponsored by The New Role of STAT Creatinine Testing Presenter: Brad S. Karon MD, PhD Sponsored by We will begin shortly. If you need assistance with audio, call 434 202 8365. Brad S. Karon MD, PhD Director, Point

More information

Advanced Clinical Decision Support & Acute Kidney Injury

Advanced Clinical Decision Support & Acute Kidney Injury Advanced Clinical Decision Support & Acute Kidney Injury Dr Jamie Coleman Senior Lecturer in Clinical Pharmacology and Honorary Consultant Physician eprescribing & CDS in Birmingham, UK Jamie Coleman 1

More information

Renal Disease in Type 2 Diabetes Mellitus

Renal Disease in Type 2 Diabetes Mellitus Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman

More information

The Trial to Assess Chelation Therapy (TACT)

The Trial to Assess Chelation Therapy (TACT) The Trial to Assess Chelation Therapy (TACT) Chelation-Placebo Comparison Gervasio A. Lamas MD Professor of Clinical Medicine Columbia University Division of Cardiology Mount Sinai Medical Center Miami

More information

Anticoagulants in Atrial Fibrillation

Anticoagulants in Atrial Fibrillation Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives

More information

UC San Diego Health System Intravenous Contrast Media Guidelines Adult Approved by P&T Committee 6/18/2014

UC San Diego Health System Intravenous Contrast Media Guidelines Adult Approved by P&T Committee 6/18/2014 UC San Diego Health System Intravenous Contrast Media Guidelines Adult Approved by P&T Committee 6/18/2014 Policy Statement To establish guidelines for the prevention, diagnosis and treatment of contrast

More information

Using Kidney Biomarkers for AKI: Risk Assessment, Diagnosis and Staging. Jay L. Koyner MD Section of Nephrology University of Chicago

Using Kidney Biomarkers for AKI: Risk Assessment, Diagnosis and Staging. Jay L. Koyner MD Section of Nephrology University of Chicago Using Kidney Biomarkers for AKI: Risk Assessment, Diagnosis and Staging Jay L. Koyner MD Section of Nephrology University of Chicago Disclosure Research funding from NIH/NIDDK /NHLBI Abbott / Abbvie Astute

More information

Acute Kidney Injury. An information guide

Acute Kidney Injury. An information guide TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION Acute Kidney Injury An information guide Acute Kidney Injury What is acute kidney injury (AKI)? Acute Kidney Injury or AKI is a sudden and

More information

Albuminuria versus GFR as markers of diabetic CKD progression

Albuminuria versus GFR as markers of diabetic CKD progression Albuminuria versus GFR as markers of diabetic CKD progression KDIGO Controversies Conference: Diabetic Kidney Disease New Delhi, March 2012 Richard J MacIsaac PhD FRACP Director of Endocrinology & Diabetes,

More information

Blood Pressure Classification. Blood Pressure Classification

Blood Pressure Classification. Blood Pressure Classification Blood Pressure Classification Blood Pressure Classification BP Classification SBP mmhg DBP mmhg Normal

More information

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY (DAPT) Dual antiplatelet regimen

More information

Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1

Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm (See NICE Clinical Guideline CG73 1 and Quality Standards 2 ) Who should have

More information

Aus der Medizinischen Klinik mit Schwerpunkt Kardiologie, Campus Virchow-Klinikum der Medizinischen Fakultät der Charité - Universitätsmedizin Berlin

Aus der Medizinischen Klinik mit Schwerpunkt Kardiologie, Campus Virchow-Klinikum der Medizinischen Fakultät der Charité - Universitätsmedizin Berlin Aus der Medizinischen Klinik mit Schwerpunkt Kardiologie, Campus Virchow-Klinikum der Medizinischen Fakultät der Charité - Universitätsmedizin Berlin DISSERTATION Risk of Contrast-Induced Nephropathy (CIN)

More information

Stroke Trial Results 2013

Stroke Trial Results 2013 Stroke Trial Results 2013 Brian Silver, MD, FAHA Director, Stroke Center Rhode Island Hospital Associate Professor of Neurology The Warren Alpert Medical School of Brown University October 18, 2013 Presenter

More information

Conflict of Interest Disclosure Statement. Obstacles. Objectives. Doctor of Nursing Practice. The Perfect Storm

Conflict of Interest Disclosure Statement. Obstacles. Objectives. Doctor of Nursing Practice. The Perfect Storm How to Effectively Institute a Scholarly Inquiry/Research Program in a Practice Doctorate Curriculum Conflict of Interest Disclosure Statement I have no financial relationships with any commercial interest

More information

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.

More information

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Septic Shock: Pharmacologic Agents for Hemodynamic Support Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Objectives Define septic shock and briefly review pathophysiology Outline receptor

More information

0by25 AN ISN HUMAN RIGHTS INITIATIVE. Global Snapshot Human Subjects Application Template. Human Research Protections Program RESEARCH PLAN

0by25 AN ISN HUMAN RIGHTS INITIATIVE. Global Snapshot Human Subjects Application Template. Human Research Protections Program RESEARCH PLAN 0by25 AN ISN HUMAN RIGHTS INITIATIVE Global Snapshot Human Subjects Application Template Human Research Protections Program RESEARCH PLAN 1. PROJECT TITLE Global Assessment of Acute Kidney Injury Incidence

More information

Renal Function test (RFT)

Renal Function test (RFT) Renal Function test (RFT) creatinine &GFR T.A Khadija Balubaid kbalubaid@kau.edu.sa KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (BIOC 416) 2013 Creatinine Creatinine is a

More information

Challenges with Clinical Trials in Nephrology. Bruce Culleton, MD MSc FRCPC University of Calgary

Challenges with Clinical Trials in Nephrology. Bruce Culleton, MD MSc FRCPC University of Calgary Challenges with Clinical Trials in Nephrology Bruce Culleton, MD MSc FRCPC University of Calgary Challenges (with the design, conduct, and interpretation) of Clinical Trials in Nephrology Bruce Culleton,

More information

Hydration Protocol for Cisplatin Chemotherapy

Hydration Protocol for Cisplatin Chemotherapy Betsi Cadwaladr University Health Version: 1.3 CSPM2 Hydration Protocol for Cisplatin Chemotherapy Date to be reviewed: July 2018 No of pages: 9 Author(s): Tracy Parry-Jones Author(s) title: Lead Cancer

More information

2. LM is a 67-year-old man admitted with esophageal cancer. Patient parameters are height 185 cm (6'1") and weight

2. LM is a 67-year-old man admitted with esophageal cancer. Patient parameters are height 185 cm (6'1) and weight CHAPTER 27. FLUID & ELECTROLYTES, SELF-ASSESSMENT QUESTIONS 1. Which of the following may cause an osmolar gap? A. Ethanol B. Lorazepam C. Mannitol D. A and B only E. All of the above are correct 2. LM

More information

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Introduction CKD의 정의와 egfr의 측정 CKD의 risk factor와 mechanism 한국의 CKD prevalence 와 prognosis CKD의 치료와

More information

Does Diabetes Control Matter?

Does Diabetes Control Matter? Does Diabetes Control Matter? Laurence Kennedy, MD, FRCP Endocrinology Department Cleveland Clinic, OH Disclosures None Does Diabetes Control Matter? Generality of patients Relative Risk Complications

More information

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in

More information

POAC CLINICAL GUIDELINE

POAC CLINICAL GUIDELINE POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal

More information

None. Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management. 76 year old male LINGO 1/5/2015

None. Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management. 76 year old male LINGO 1/5/2015 Financial Disclosure Information Dual Antiplatelet Therapy Plus Systemic Anticoagulation: Bleeding Risk and Management Robert D. McBane, M.D. Division of Cardiology Mayo Clinic Rochester Dual Antiplatelet

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants

Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants Traffic light classification- Amber 2 Information sheet for Primary Care Prescribers Relevant Licensed Indications

More information

Prediction of Kidney Disease Progression in Patients with Diabetes

Prediction of Kidney Disease Progression in Patients with Diabetes Prediction of Kidney Disease Progression in Patients with Diabetes John Arthur, MD, PhD Medical University of South Carolina SEKDC Meeting September 8, 2012 Objectives Understand the importance of predicting

More information

For the NXT Investigators

For the NXT Investigators Diagnostic performance of non-invasive fractional flow reserve derived from coronary CT angiography in suspected coronary artery disease: The NXT trial Bjarne L. Nørgaard, Jonathon Leipsic, Sara Gaur,

More information

Absolute cardiovascular disease risk management

Absolute cardiovascular disease risk management Quick reference guide for health professionals Absolute cardiovascular disease risk management This quick reference guide is for use by health professionals for primary prevention of cardiovascular disease

More information

Evaluation of Chronic Kidney Disease in Geriatric Patients

Evaluation of Chronic Kidney Disease in Geriatric Patients Evaluation of Chronic Kidney Disease in Geriatric Patients Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Review prevalence of chronic

More information

Organization and Structure of a Peritoneal Dialysis Program: an important ingredient for success

Organization and Structure of a Peritoneal Dialysis Program: an important ingredient for success Organization and Structure of a Peritoneal Dialysis Program: an important ingredient for success Fredric O. Finkelstein Hospital of St. Raphael, Yale University New Haven. CT 1 Overview of Presentation

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Understanding. Chronic Kidney Disease

Understanding. Chronic Kidney Disease R E N A L R E S O U R C E C E N T R E Understanding Chronic Kidney Disease Causes of Chronic Kidney Disease Most causes of chronic kidney failure are diseases that are not usually accompanied by symptoms

More information

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes

More information

U p d at e. Key Advisor: Professor Rob Walker. keyword: Renal Impairment. 18 I BPJ I Issue 6

U p d at e. Key Advisor: Professor Rob Walker.  keyword: Renal Impairment. 18 I BPJ I Issue 6 U p d at e Key Advisor: Professor Rob Walker 18 I BPJ I Issue 6 www.bpac.org.nz keyword: Renal Impairment Action plan for Chronic Kidney Disease (Based on egfr) egfr ml/min/1.73 m 2 Description Clinical

More information

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013 Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013 Family physician with Rivergrove Medical Clinic Practice in the north end since 1985 Medical Director of the Wellness

More information

Prevention of Acute COPD exacerbations

Prevention of Acute COPD exacerbations December 3, 2015 Prevention of Acute COPD exacerbations George Pyrgos MD 1 Disclosures No funding received for this presentation I have previously conducted clinical trials with Boehringer Ingelheim. Principal

More information

General PROVIDER INITIAL: PHYSICIAN ORDERS. Vital Signs

General PROVIDER INITIAL: PHYSICIAN ORDERS. Vital Signs Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 Discontinue all lorazepam

More information

Treatment Recommendations for CKD in Cats (2015)

Treatment Recommendations for CKD in Cats (2015) All treatments for chronic kidney disease (CKD) need to be tailored to the individual patient. The following recommendations are useful starting points for the majority of cats at each stage. Serial monitoring

More information

WITHDRAWAL OF ANALGESIA AND SEDATION

WITHDRAWAL OF ANALGESIA AND SEDATION WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses

More information

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest

More information

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Athersclerotic Risk Lynne T Braun, PhD, CNP, FAHA, FAAN Professor of Nursing, Nurse Practitioner Rush University Medical Center 2

More information